Actively Recruiting
Assessment of Breathing Pattern During NIV
Led by Fisher and Paykel Healthcare · Updated on 2025-05-11
40
Participants Needed
1
Research Sites
31 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
COPD and OHS are respiratory conditions that disrupt normal breathing. Positive airway pressure, specifically Non-Invasive Ventilation (NIV), has been shown to improve breathing and reduce symptoms in patients with these conditions. Regular use of NIV can lead to better symptom management, improved quality of life, and reduced use of healthcare resources. The type of mask used for breathing support can greatly affect a patient's comfort and willingness to use it. For conditions like Obstructive Sleep Apnea (OSA), which is a physical blockage of the airway caused by the relaxation of the muscles of the throat, nasal masks are often used because they are comfortable and work well. But for breathing support in the hospital, full face masks are typically used because patients are having significant trouble breathing and tend to breathe through their mouth. However, it's important to note that we don't yet fully understand the best way to provide breathing support for long-term NIV users, like COPD and OHS patients. The understanding of breathing route is currently only established for OSA. However, conditions like COPD affect the lungs and the overall system used for breathing, which is different from the throat blockage seen in OSA. So, the assumptions we make based on conditions like OSA may not apply to these other conditions. More research is needed to understand this better.
CONDITIONS
Official Title
Assessment of Breathing Pattern During NIV
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 18 years
- Prescribed nocturnal Non-Invasive Ventilation (NIV) for COPD or Obesity Hypoventilation Syndrome (OHS)
- Able to complete an overnight sleep study
- Comfortable to sleep on a standard double bed
- Capacity to complete informed consent
You will not qualify if you...
- Uncontrolled sleep apnea with Apnea-hypopnea index (AHI) over 15 events/hour off personal NIV device data
- Prescribed inspiratory positive airway pressure (IPAP) above 25 cmH2O
- Self-reported pregnancy
- Allergy to adhesive of the sensors
- Self-reported cold or flu symptoms
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fisher and Paykel Healthcare Sleep Laboratory
Auckland, New Zealand, 2013
Actively Recruiting
Research Team
V
Valeria Mereacre, PhD Physiology
CONTACT
J
Jessica Fogarin
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
BASIC_SCIENCE
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here